[1]Patent:WO2014/75077,2014,A1
[1]CurrentPatentAssignee:NEUPHARMAINC-WO2014/75077,2014,A1Locationinpatent:Paragraph0229
945756-49-0
218301-87-2
1033726-21-4
380430-49-9
874290-59-2
2377610-16-5
362-74-3 | Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate)2'-butanoate | AA00I73L | MFCD00243003
871353-01-4 | 3-Bromo-2-fluorothioanisole | AA00IEAT | MFCD22488888
1780552-69-3 | tert-Butyl n-(octahydrocyclopenta[c]pyrrol-5-yl)carbamate | AA00IL6P | MFCD24445529
107910-75-8 | Ganciclovir sodium | AA019FT1 | MFCD00873979
1864057-87-3 | 4-(AZETIDIN-3-YLMETHYL)PYRIDINE DIHYDROCHLORIDE | AA01AS5R | MFCD28166139
2090138-50-2 | 4,4,4-trifluoro-3-(methylamino)butanenitrile | AA01C7H5 | MFCD31438380
12225-06-8 | 2-Naphthalenecarboxamide,N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]- | AA01DQ3X | MFCD09839189
145224-99-3 | Calcium-Like Peptide H-Val-Ala-Ile-Thr-Val-Leu-Val-Lys-OH | AA01E6NN | MFCD00171735
1202864-39-8 | XylenolOrange | AA01FPM6 | MFCD00014580
154258-06-7 | 1-(3-Chloro-2,4-difluorophenyl)ethan-1-one | AA01FPW3 | MFCD28555551